Imagine Pharma announced today that it has successfully completed more than 32 clinical islet cell isolation procedures for several leading hospital systems across the United States, including the Cincinnati Children’s Hospital Medical Center.
| Partners with Cook MyoSite to establish a state-of-the-art facility to conduct human islet isolations for hospital systems without in-house capabilities PITTSBURGH, Dec. 19, 2023 /PRNewswire/ -- Imagine Pharmaceuticals, Inc., a biotech company focused on advancing the commercialization of its novel IMG-1 polypeptide in Oral Delivery, Therapeutics, and Regenerative Medicine, announced today that it has successfully completed more than 32 clinical islet cell isolation procedures for several leading hospital systems across the United States, including the Cincinnati Children’s Hospital Medical Center. As part of expanding its clinical islet cell isolation capabilities, Imagine Pharma has also formed a partnership with Cook MyoSite, enabling the Company to support those hospital systems without their own in-house isolation facilities. Human islet cell isolation and preparation involve specialized expertise and costly processes, typically available in only a handful of hospital facilities and outside laboratories. Under the leadership of Dr. Rita Bottino, Director of Imagine Pharma’s Islet Programs and a globally-renowned expert in islet isolations, Imagine has quickly established itself as a leader in both research and clinical islet isolation procedures, pioneering advancements in the treatment of pancreatitis and auto-islet transplants. “The availability of high-quality human islet cells is critical to medical centers that perform autologous transplantations for patients undergoing pancreatectomies,” said Bottino. “Our prominence in clinical isolations and the increasing demand for our expertise are testaments to the trust the medical community has placed in us to perform this very specialized procedure.” “We are proud to collaborate with Imagine Pharma in their pursuit of innovative medical solutions and to support their clinical work at our cutting-edge facilities,” said Carl Cook, President of Cook MyoSite, Inc. “Our commitment to excellence aligns with Imagine Pharma’s mission, and we look forward to expanding our partnership in the year ahead.” Imagine Islet Center About Imagine Pharma About Cook MyoSite Contact: Andie Levine, andie@0to5.com
SOURCE Imagine Pharma |
View original content:
